Kistler-Tiffany Companies’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Kistler-Tiffany Companies’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-300	Closed	-$41K	–	696
2020 Q3	$41K	Hold	300	–	–	0.01%	301
2020 Q2	$29K	Hold	300	–	–	0.01%	317
2020 Q1	$22K	Hold	300	–	–	0.01%	350
2019 Q4	$22K	Buy	+300	New	+$18.2K	0.01%	357

Kistler-Tiffany Companies's MYOK Position: Q4 2020 in Review

Kistler-Tiffany Companies sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 300 shares — an estimated $41K sold.

Kistler-Tiffany Companies first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $41K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Kistler-Tiffany Companies reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Kistler-Tiffany Companies sold 300 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $41K.
Kistler-Tiffany Companies first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Kistler-Tiffany Companies's MyoKardia, Inc. Common Stock position peaked at $41K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2020, filed 3 Feb 2021.